Helge Garåsen The Trondheim Model - NSDM
Helge Garåsen The Trondheim Model - NSDM
Helge Garåsen The Trondheim Model - NSDM
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
(p=0.003), and mean difference in cost per day at risk per patient was EUR 37 (95 % CI 1-71)<br />
(p=0.003).<br />
Results after 12 months<br />
Thirty-five patients, 13 (18.1 %) of all patients included in the intervention group and 22<br />
(31.4 %) in the general hospital group, died within 12 months (p= 0.03). Patients in the<br />
intervention group were observed during a longer period of time than in the general hospital<br />
group; 335.7 (95 % CI 312.0-359.4) versus 292.8 (95 % CI 264.1-321.5) days (p=0.01). <strong>The</strong>re<br />
were statistically no differences in the need for long-term primary level care or in the number<br />
of admissions or days spent in general hospital beds.<br />
Average total health services costs per patient per observed day were EUR 76 (95 % CI 56-<br />
95) for the intervention group and EUR 100 (95 % CI 80-120) for the general hospital group<br />
(p=0.03).<br />
Trial registration<br />
ClinicalTrials.gov NCT00235404<br />
Conclusions Study II<br />
Intermediate care in a community hospital significantly decreased the number of readmissions<br />
for the same disease to general hospital and a significantly higher number of patients were<br />
independent of community care after 26 weeks of follow-up. <strong>The</strong>re was no increase in<br />
mortality and number of days in institutions.<br />
Care at intermediate level in a community hospital was cost effective from a health service<br />
perspective and contributes to better patient outcome as more patients had better functional<br />
status and significantly fewer patients were dead after 12 months follow-up.<br />
9